Cerebral Palsy: Wayne State University Giving Hope In a Small (Nano) Way by O\u27Connor, Julie
New Science
Volume 18 | Issue 1 Article 13
9-1-2010
Cerebral Palsy: Wayne State University Giving
Hope In a Small (Nano) Way
Julie O'Connor
Wayne State University
Follow this and additional works at: http://digitalcommons.wayne.edu/newscience
This Article is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in New Science by an
authorized administrator of DigitalCommons@WayneState.
Recommended Citation




Scientists in Wayne State’s College of Engineering 
and School of Medicine are creating a novel drug-
carrying nanodevice for the treatment of cerebral 








Cerebral palsy, a neurological disorder that appears in infancy or early childhood and 
permanently affects body movement and muscle 
coordination, affects 10,000 newborns yearly 
and 800,000 people overall in the U.S. It occurs 
as a result of injury to the developing brain that 
happens before birth or sometimes during the 
first few months or years of life. Conditions such 
as prematurity, maternal infections, placental 
abnormalities and infections such as meningitis or 
encephalitis that occur in the newborn period may 
result in brain injury producing cerebral palsy.
A team of researchers from the College of 
Engineering, School of Medicine and the National 
Institutes of Health’s Perinatal Research Branch 
have been collaborating to discover and develop 
new nanodevices that will aid in the diagnosis 
and treatment of neuroinflammatory diseases and 
infections that currently are difficult to target  
and treat.  
The team led by Rangaramanujam Kannan, 
Ph.D., professor of chemical engineering in the 
College of Engineering, with collaborators Sujatha 
Kannan, M.D., assistant professor of pediatrics in 
the School of Medicine and Roberto Romero, M.D., 
chief of the National Institute of Child Health 
& Human Development’s Perinatology Research 
Branch (PRB) housed at Wayne State University 
and the Detroit Medical Center, is developing a 
therapeutic approach that will target and treat 
neuroinflammation in cerebral palsy. By developing 
nanotechnology-based diagnostic and therapeutic 
approaches for prevention and treatment of 
maternal infections and fetal brain injury, this 
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team’s promising approach may one day eliminate 
or lessen the incidences of cerebral palsy, along 
with other neuroinflammatory diseases such as 
age-related macular degeneration, Alzheimer’s, 
multiple sclerosis, amytrophic lateral sclerosis and 
Parkinson’s disease.   
These dendrimer-based nanodevices will 
target and deliver drugs across the blood-brain 
barrier. According to the research team, their 
results are the first to show that dendrimers are 
able to target the specific site of injury in the 
brain in a neuroinflammation model. Using this 
nanotherapeutic approach, the targeted drugs are 
10 to 100 times more effective than free drugs upon 
intravenous administration. 
“There is an increasing body of literature, in 
addition to evidence from our own research 
relating to the disease mechanisms, that suggests 
that neuroinflammation plays a key role in the 
pathogenesis and evolution of cerebral palsy and 
other diseases,” said R. Kannan. “We hope to 
develop therapeutic approaches that will target and 
treat neuroinflammation resulting in significantly 
improved treatment outcomes.”
A wide variety of neurological diseases are very 
difficult to treat due to lack of technology able to 
target the affected regions in the central nervous 
system. “We believe that our novel drug-carrying 
nanodevice will offer solutions for treatment of 
such conditions by delivering drugs to the specific 
target,” R. Kannan added. 
Dr. Sujatha Kannan has established an animal 
model of inflammation that results in a phenotype 
of cerebral palsy. She, in collaboration with 
Dr. Diane Chugani, professor of pediatrics and 
radiology in the School of Medicine, and the 
Positron Emission Tomography Center, has shown 
that the presence of neuroinflammation can be 
detected at a very early stage using noninvasive 
imaging by Positron Emission Tomography. 
Clinical translational studies for the detection of 
neuroinflammation in at-risk newborns  
are ongoing. 
“The PRB has established a unit to develop 
applications of nanotechnology in perinatal 
medicine under the leadership of Dr. R. Kannan 
because we are convinced that this approach will 
enhance early diagnosis of inflammation in utero 
as well as treatment,” commented Dr. Romero. 
“Dr. Sujatha Kannan and Dr. R. Kannan have 
explored potential mechanisms to prevent and treat 
inflammation-induced cerebral palsy. Application 
to humans requires new methods for diagnosis and 
drug delivery into the amniotic cavity. Such goals 
could be accomplished using nanotechnology and, 
hence, the partnership between Dr. Kannan and 
the Perinatology Research Branch,” Dr. Romero 
added. The PRB nanotechnology lab now has 
six postdoctoral researchers and two graduate 
students with broad research expertise ranging 
from chemistry, engineering, neuroscience, 
pharmacology, cell biology, animal model 
development and imaging.
This novel and high-risk research was initially 
funded by the Ralph Wilson Medical Research 
Foundation, which provides money for cutting-edge 
research in the hope that a breakthrough will be 
made to find a cure for devastating conditions such 
as cerebral palsy. Rapid advancements in maternal-
fetal medicine have been enabled by the support 
from the PRB. Through the technology being 
developed by the Kannan and PRB team, there soon 
may be a more effective and safe treatment method 
for treating the fetus/newborn for cerebral palsy and 
a variety of neurodegenerative conditions that are 
difficult to treat.
To learn more, visit: http://www.kannangroup.com
Nanomedicine








About Dr. Rangaramanujam Kannan 
Dr. R.M. Kannan received his B.E. in chemical 
engineering from the Birla Institute of Technology, and 
a Ph.D. in chemical engineering from the California 
Institute of Technology. He joined Wayne State 
University in 1997.
About Dr. Sujatha Kannan:  
Dr. Sujatha Kannan received her M.B.B.S degree 
from the Jawaharlal Nehru Institute of Postgraduate 
Medical Education and Research (JIPMER, India), 
and completed her pediatric residency and critical 
care medicine fellowship at WSU/Children’s Hospital 
of Michigan. She joined WSU/Children’s Hospital of 
Michigan as faculty in 2003.
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